{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-069099","form_type":"8-K","ticker":"TELA","cik":"0001561921","company_name":"TELA Bio, Inc.","filed_at":"2024-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.967664+00:00","generated_at":"2026-06-01T05:54:04.684021+00:00","sec_items":["5.02","5.07","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"TELA Bio appoints Jeffrey Blizard to Board; stockholders re-elect directors","bullets":["Jeffrey Blizard, Global Head of Surgical Sales at Abiomed (J&J MedTech), appointed to Board as Class III director, term to 2025 annual meeting.","Initial equity grant: option for 9,300 shares vesting monthly over 36 months and RSU for 6,375 shares vesting in three annual installments.","Annual retainer: $45,000 for Board service plus $5,000 for Nominating Committee.","Stockholders elected Kurt Azarbarzin (17,037,112 for) and Antony Koblish (18,742,180 for) as Class II directors; KPMG ratified as auditor for FY2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-069099","json":"https://secwatch.observer/filing/0001104659-24-069099.json","markdown":"https://secwatch.observer/filing/0001104659-24-069099.md","text":"https://secwatch.observer/filing/0001104659-24-069099.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1561921/000110465924069099/0001104659-24-069099-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1561921/000110465924069099/tm2416416d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:54:04.684021+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"eae3038318","claim":"Jeffrey Blizard was appointed as member of the Board of Directors at TELA Bio, Inc..","evidence_excerpt":"On June 4, 2024, TELA Bio, Inc. (the “ Company ”) appointed Jeffrey Blizard as a member of the Company’s Board of Directors (the “ Board ”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1561921/000110465924069099/0001104659-24-069099-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"member of the Board of Directors"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}